Literature DB >> 12532377

Two reaction sites of a spin label, TEMPOL (4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl), with hydroxyl radical.

Keita Saito1, Keizo Takeshita, Jun-Ichi Ueda, Toshihiko Ozawa.   

Abstract

The exposure of 4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl (TEMPOL) to hydroxyl radical ((.)OH) led to the appearance of a new triplet ESR signal along with a reduction in the intensity of the TEMPOL signal. The observed spectrum was in good agreement with the spectrum simulated with 4-oxo-2,2,6,6-tetramethylpiperidine-N-oxyl (TEMPON) and TEMPOL, and the addition of sodium borohydride to the product solution led to the disappearance of the new signal. These results indicate the formation of TEMPON during the reaction. A comparison of the concentration of TEMPON formed with that of nitroxyl compounds that lost the electron spin resonance (ESR) signal showed that the rate of TEMPON formation is less than one-tenth that of the paramagnetism loss caused by (.)OH in the pH range 6.5-8.5. These results indicate that TEMPOL has two reaction sites with (.)OH; the nitroxyl group and the 4-position of the piperidine ring. The reaction at the 4-position should contribute to the (.)OH scavenging activity of TEMPOL together with that at the nitroxyl group, although the rate of the former reaction is relatively low. Copyright 2003 Wiley-Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 92:275-280, 2003

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12532377     DOI: 10.1002/jps.10304

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  16 in total

Review 1.  Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

2.  Prevention of oxidative damage to lens by caffeine.

Authors:  Shambhu D Varma; Kavita R Hegde
Journal:  J Ocul Pharmacol Ther       Date:  2010-02       Impact factor: 2.671

3.  The effect of structure on nitroxide EPR spectral linewidth.

Authors:  Scott R Burks; Mallory A Makowsky; Zachary A Yaffe; Chad Hoggle; Pei Tsai; Sukumaran Muralidharan; Michael K Bowman; Joseph P Y Kao; Gerald M Rosen
Journal:  J Org Chem       Date:  2010-07-16       Impact factor: 4.354

4.  Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation.

Authors:  Jeffrey J Lochhead; Gwen McCaffrey; Colleen E Quigley; Jessica Finch; Kristin M DeMarco; Nicole Nametz; Thomas P Davis
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-17       Impact factor: 6.200

Review 5.  Effects of tempol and redox-cycling nitroxides in models of oxidative stress.

Authors:  Christopher S Wilcox
Journal:  Pharmacol Ther       Date:  2010-02-11       Impact factor: 12.310

6.  Creatine and tempol attenuate noise-induced hearing loss.

Authors:  Shujiro B Minami; Daisuke Yamashita; Kaoru Ogawa; Jochen Schacht; Josef M Miller
Journal:  Brain Res       Date:  2007-02-21       Impact factor: 3.252

7.  A mitochondria-targeted triphenylphosphonium-conjugated nitroxide functions as a radioprotector/mitigator.

Authors:  Jianfei Jiang; Detcho A Stoyanovsky; Natalia A Belikova; Yulia Y Tyurina; Qing Zhao; Muhammad A Tungekar; Valentyna Kapralova; Zhentai Huang; Arlan H Mintz; Joel S Greenberger; Valerian E Kagan
Journal:  Radiat Res       Date:  2009-12       Impact factor: 2.841

Review 8.  Chemistry and antihypertensive effects of tempol and other nitroxides.

Authors:  Christopher S Wilcox; Adam Pearlman
Journal:  Pharmacol Rev       Date:  2008-12       Impact factor: 25.468

Review 9.  Drug delivery to the ischemic brain.

Authors:  Brandon J Thompson; Patrick T Ronaldson
Journal:  Adv Pharmacol       Date:  2014-08-22

10.  Systemically administered tempol reduces neuronal activity in paraventricular nucleus of hypothalamus and rostral ventrolateral medulla in rats.

Authors:  Shun-Guang Wei; Zhi-Hua Zhang; Yang Yu; Robert B Felder
Journal:  J Hypertens       Date:  2009-03       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.